Lantheus Holdings Inc. (NASDAQ:LNTH) shares dropped 2.5% during trading on Thursday . The stock traded as low as $4.58 and last traded at $4.64, with a volume of 55,939 shares traded. The stock had previously closed at $4.76.

LNTH has been the topic of several recent analyst reports. Zacks Investment Research downgraded Lantheus Holdings from a “hold” rating to a “sell” rating in a report on Wednesday, March 30th. Robert W. Baird reissued a “hold” rating on shares of Lantheus Holdings in a report on Monday, April 11th. Finally, Jefferies Group reissued a “buy” rating on shares of Lantheus Holdings in a report on Wednesday, May 4th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Lantheus Holdings has a consensus rating of “Buy” and a consensus price target of $5.65.

The stock’s market cap is $156.09 million. The stock has a 50-day moving average of $3.29 and a 200-day moving average of $2.45.

Lantheus Holdings (NASDAQ:LNTH) last issued its quarterly earnings data on Tuesday, May 3rd. The company reported $0.34 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.06 by $0.28. The company had revenue of $76.50 million for the quarter, compared to analyst estimates of $72.43 million. On average, analysts expect that Lantheus Holdings Inc. will post $0.35 earnings per share for the current year.

Lantheus Holdings, Inc is a holding company. The Company, through Lantheus Medical Imaging, Inc, develops, manufactures, sells and distributes diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. It operates in two geographical segments: U.S.